Case Report

A-41 years old male with alcoholic cardiomyopathy at Tabanan General Hospital, Bali-Indonesia: a case report

Gede Wikananda , Eka Ariawan, Ary Priadnyana

Gede Wikananda
General Practitioner at Cardiovascular Department BRSU Tabanan Hospital, Bali, Indonesia. Email:

Eka Ariawan
Cardiologist at BRSU Tabanan Hospital, Bali, Indonesia

Ary Priadnyana
Senior clerkship at Sanglah General Hospital, Bali, Indonesia
Online First: August 01, 2019 | Cite this Article
Wikananda, G., Ariawan, E., Priadnyana, A. 2019. A-41 years old male with alcoholic cardiomyopathy at Tabanan General Hospital, Bali-Indonesia: a case report. Intisari Sains Medis 10(2). DOI:10.15562/ism.v10i2.437

Background: Alcoholic cardiomyopathy is a form of toxic cardiomyopathy which develops as a result of long-standing chronic ingestion of alcohol. Its clinical findings share similar features to other forms of dilated cardiomyopathy. Diagnosis can be made based on the history of long term alcohol abuse, clinical findings, and supporting diagnostic studies. This case report aims to overview alcoholic cardiomyopathy; from establishing the initial diagnosis to the treatment given for the condition.

Case Description: A 41 years old male came to the emergency department unit with shortness of breath since last few days. Shortness of breath was said to be getting worse over time and progressed to breathlessness at rest. Other complaints were palpitations, fatigue, and long-standing cough. The patient was found to have a history of drinking alcohol in large quantities since 27 years ago. The blood pressure was 110/70 mm Hg, pulse rate 105 beats/min, and respiratory rate was 20 breaths/min. Slight edemas on both legs were also found.  From auscultation examination, bibasilar crepitation on both lungs was found. Cardiac examination showed systolic murmur of mitral regurgitation (MR) and tricuspid regurgitation (TR).  On supporting investigation, a chest x-ray showed cardiomegaly (cardiothoracic ratio; 57%). ECG examination showed sinus tachycardia and left atrial (LA) and left ventricular (LV) enlargement. Trans-thoracal echocardiographic (TTE) examination revealed; RWMA: global hypokinetic-akinetic, multi-chamber dilated and severe LV systolic dysfunction (EF 29%) and diastolic function (Grade IV (E/A Ratio>4)). Valve examination showed moderate-severe MR and moderate TR (TVG 40 mmHg).

Conclusion: Alcohol cardiomyopathy is one of the most common causes of heart failure in young age and carries a poor prognosis if not treated properly. Treatment of alcoholic cardiomyopathy mainly includes total alcohol abstinence along with drugs used to treat systolic heart failure to reverse the condition and correct any nutritional deficiencies.


Uchenna DI, Anyalechi JI, Jesuorobo DE. Alcoholic Cardiomyopathy in A 39 Year Old Female: A Case Report. The Internet Journal of Cardiology. 2010; 10(1):1-5

Balitbang Kemenkes RI. Tingkat Konsumsi Alkohol. Riset Kesehatan Dasar; RISKESDAS. Jakarta: Balitbang Kemenkes RI. 2018

Guzzo-Merello G, Cobo-Marcos M, Gallego-Delgado M, Garcia-Pavia P. Alcoholic cardiomyopathy. World J Cardiol. 2014;6(8):771-81

Mahmoud S, Beauchesne LM, Davis DR, Glover C. Acute reversible left ventricular dysfunction secondary to alcohol. Can J Cardiol. 2007;23(6):475-477

Johnson BA, Addolorato G, Leggio L, d'Angelo C, et al. Physical considerations for treatment complications of alcohol and drug use and misuse. In: Johnson BA ed Addiction medicine. Springer Science and Business Media, LLC. 2011;1115–45

Maisch B. Alcoholic cardiomyopathy, the result of dosage and individual predisposition. Herz 2016.41(6):484-493

Towbin, Jeffrey A., Lorts, Angela. Arrhythmias and Dilated Cardiomyopathy. Journal of the american college of cardiology. 2011;57(21):2169-71

Mumtaz A, Setiawan A. Faktor resiko kardiomiopati dilatasi di rumah sakit dr. Kariadi Semarang. Jurnal Kedokteran Diponegoro. 2017;6(1);20-27

Donal E, De Place C, Kervio G, Bauer F, Gervais R, Leclercq C, et al. Mitral regurgitation in dilated cardiomyopathy: value of both regional left ventricular contractility and dyssynchrony. Eur J Echocardiogr. 2009;10(1):133-8.

Punnose L, Burkhoff D, Cunningham L, Horn EM. Functional mitral regurgitation: therapeutic strategies for a ventricular disease. J Card Fail. 2014; 20(4):252-67.

Kanzaki H, Bazaz R, Schwartzman D, Dohi K, Sade LE, Gorcsan J 3rd. A mechanism for immediate reduction in mitral regurgutation after cardiac resynchronization therapy: insights from mechanical activation strain mapping, J Am Coll Cardiol. 2004;44:1619-1625

Mojadidi, Mohammad K, Zaman Muhammad O, Elgendy Islam Y, et al. Patent foramen ovale closure: What are the Indications? A summary of lessons learned from positive randomized trial data. Cardiac Interventions Today. 2018.12(3);28-33

No Supplementary Material available for this article.
Article Views      : 147
PDF Downloads : 70